Dual-core@shell-structured Fe3O4–NaYF4@TiO2nanocomposites as a magnetic targeting drug carrier for bioimaging and combined chemo-sonodynamic therapy
Lists
Only you see this
Abstract
Multifunctional dual-core@shell (Fe<sub>3</sub>O<sub>4</sub>-NaYF<sub>4</sub>@TiO<sub>2</sub>) nanocomposite (DCSNC) loaded with doxorubicin (DOX) have been developed for synergetic sonodynamic cancer chemotherapy, where titanium dioxide (TiO<sub>2</sub>) is employed as a sonosensitizer for sonodynamic therapy (SDT) of the tumor in deep tissues, and NaYF<sub>4</sub> is used for upconversion luminescence (UCL) imaging. After being coated with hyaluronic acid (HA), the nanocomposites exhibit a time dependent cellular uptake and an excellent nucleus targeting effect in KB and MCF-7 cells. The ultrasound of HA-DCSNCs obviously enhances the apoptosis rate of MCF-7 cells. A greater tumor inhibition rate is observed when the tumor-bearing mice are treated with combined therapy (88.36%) compared with chemotherapy (28.36%) or sonodynamic therapy (38.91%) alone, indicating the potential of sonodynamic chemotherapy for cancer treatment.
BibTeX
@article{shen2014dual,
author = {Song Shen and Xiaomeng Guo and Lin Wu and Meng Wang and Xinshi Wang and Fenfen Kong and Haijun Shen and Meng Xie and Yanru Ge and Yi Jin},
title = {{Dual-core@shell-structured Fe<sub>3</sub>O<sub>4</sub>–NaYF<sub>4</sub>@TiO<sub>2</sub>nanocomposites as a magnetic targeting drug carrier for bioimaging and combined chemo-sonodynamic therapy}},
journal = {Journal of Materials Chemistry B},
year = {2014},
doi = {10.1039/c4tb00841c},
}Loading related content...